Research
Click on a title below to read or download the full article in pdf format.
Published Journal Articles
Interested in Clinical Trial Participation?
Patients, Health Care Professionals and Researchers interested in participating in our clinical trials can contact the clinical trial sites for eligibility criteria and enrollment information.
What Are We Discovering for Patients & Caregivers?
There is Hope When Immune-12 is approved by regulatory bodies like the FDA or TGA, it could mark a major advancement for patients and families—especially
Clinical Trials
PMB’s Primary Area of Focus
PMB’s focus is on launching clinical trials for GBM and DIPG using its product, Immune12, a complex biologic compound derived from marine organisms.
GBM and DIPG are orphan diseases with no cure. Current treatments may extend life by several months but are not curative.
Upon diagnosis, patients face a grim reality with little to no hope for recovery. While existing standard-of-care treatments like radiation and chemotherapy may extend life by a few months, they fall significantly short of providing a cure. Moreover, the side effects associated with these treatments can be severe and debilitating, further compromising the quality of life for patients.
Media & Press Inquiries
Pacific Marine Biotech, LLC8 Church Street, First FloorTorrington, Connecticut, 06790 USA Phone : (959) 901-4041Email : info@pacificmarinebiotech.comWeb site : www.pacificmarinebiotech.com Media and Press InquiriesJames SokEmail